Fulltext

Safety of pregabalin among hemodialysis patients suffering from uremic pruritus

Khan TM 1 , Alhafez AA 2 , Syed Sulaiman SA 3 , Bin Chia DW 1

Affiliations 

  • 1 School of Pharmacy, Monash University, Bundar Sunway, 45700 Selangor, Malaysia
  • 2 Director, Aljaber Kidney Center, Eastern Province, Alahsa, Saudi Arabia
  • 3 School of Pharmaceutical Sciences, University Sains Malaysia 11800, Pulau Pinang, Malaysia
Saudi Pharm J, 2015 Nov;23(6):614-20.
PMID: 26702255 DOI: 10.1016/j.jsps.2014.10.004

Abstract

The aim of this study was to assess the safety and probability of adverse events associated with the use of 75 mg pregabalin post hemodialysis (pHD) among patients with UP.

* Title and MeSH Headings from MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

MeSH terms
Similar publications